Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 48 of 48 entries
View as:

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Phase: N/A Priority: Normal
NCT ID: NCT06930625 Org: User:
Start: 06/30/25 End: 03/31/29 Due: 03/31/30

Mass Balance Recovery and Metabolic Profile of 14C Debio 1450 Following Single Oral and Intravenous Doses in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02595203 Org: User:
Start: 11/30/15 End: 12/31/15 Due: 12/31/16

Safety and Efficacy Study of Istaroxime in Acute Decompensated Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT00838253 Org: User:
Start: 06/30/09 End: - Due: -

Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL

Phase: N/A Priority: Normal
NCT ID: NCT02564744 Org: User:
Start: 06/05/16 End: 06/25/21 Due: 06/25/22

A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Phase: N/A Priority: Normal
NCT ID: NCT05364944 Org: User:
Start: 05/18/22 End: 12/03/24 Due: 12/03/25

Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

Phase: N/A Priority: Normal
NCT ID: NCT01467882 Org: User:
Start: 04/30/12 End: 07/31/14 Due: 07/31/15

Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00751790 Org: User:
Start: 07/31/06 End: 08/31/07 Due: 08/31/08

A Single Dose Study of Debio 1450 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02162199 Org: User:
Start: 06/30/14 End: 10/31/14 Due: 10/31/15

Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Phase: N/A Priority: Normal
NCT ID: NCT01446250 Org: User:
Start: 12/31/11 End: 05/31/13 Due: 05/31/14

A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02214433 Org: User:
Start: 08/31/14 End: 02/28/15 Due: 02/28/16

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT06969430 Org: User:
Start: 05/31/25 End: 11/30/31 Due: 11/30/32

A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients

Phase: N/A Priority: Normal
NCT ID: NCT00854802 Org: User:
Start: 01/31/09 End: 09/30/10 Due: 09/30/11

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00455767 Org: User:
Start: 07/31/06 End: 09/30/07 Due: 09/30/08

A Study to Evaluate the Absorption, Metabolism, and Excretion and Absolute Bioavailability of Xevinapant in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04962724 Org: User:
Start: 08/02/21 End: 11/09/21 Due: 11/09/22

Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02726438 Org: User:
Start: 04/30/16 End: 06/30/17 Due: 06/30/18

Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01168752 Org: User:
Start: 04/30/10 End: 04/30/13 Due: 04/30/14

Study of Debio 1450 for Bacterial Skin Infections

Phase: N/A Priority: Normal
NCT ID: NCT02426918 Org: User:
Start: 05/31/15 End: 09/30/16 Due: 09/30/17

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00423228 Org: User:
Start: 02/28/07 End: 04/30/09 Due: 04/30/10

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

Phase: N/A Priority: Normal
NCT ID: NCT01948297 Org: User:
Start: 08/31/13 End: 06/26/20 Due: 06/26/21

A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]

Phase: N/A Priority: Normal
NCT ID: NCT01714037 Org: User:
Start: 08/31/12 End: 11/30/14 Due: 11/30/15

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

Phase: N/A Priority: Normal
NCT ID: NCT01215643 Org: User:
Start: 10/31/10 End: 05/31/12 Due: 05/31/13

Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00869115 Org: User:
Start: 06/30/09 End: - Due: -

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

Phase: N/A Priority: Normal
NCT ID: NCT01970904 Org: User:
Start: 10/31/13 End: 03/31/15 Due: 03/31/16